Rapid progressive eosinophilic cardiomyopathy in a patient with Churg–Strauss syndrome (CSS)
Authors:
- 27 February 2006
- journal article
- case report
- Published by Springer Nature in Clinical Research in Cardiology
- Vol. 95 (5) , 289-294
Abstract
Churg–Strauss syndrome (CSS) is a rare necrotizing, systemic vasculitis that is almost invariably associated with bronchial asthma. Although overall prognosis is good and treatment with corticosteroids alone or in combination with other immunosuppressive agents is typically successful, there are reports of patients that do not show signs of clinical improvement under the usual pharmacotherapy. Small clinical studies suggested that cardiac or gastrointestinal involvement is associated with an adverse prognosis. We here report the case of a 38 year old male patient with a history of bronchial asthma who was admitted to our hospital for further evaluation of progressive dyspnea. Blood eosinophilia, infiltrates of both lungs, signs of necrosis and eosinophil deposits on myocardial biopsy combined with a history of bronchial asthma established the diagnosis of CSS with cardiac involvement. We initiated an immunosuppressive therapy with prednisone and methotrexate. Upon tapering of the dosage of prednisone, we noticed worsening of symptoms and further deterioration of cardiac function. Despite the addition of cyclophosphamide and adjustment of heart failure medication, we were not able to stabilize the cardiac situation. Due to rapid progressive eosinophilic cardiomyopathy associated with CSS refractory to medical therapy, our patient was placed on the urgent heart transplantation waiting list and, in the meantime, has undergone successful cardiac transplantation.Keywords
This publication has 20 references indexed in Scilit:
- Clinical and immunological effects of low‐dose IFN‐α treatment in patients with corticosteroid‐resistant asthmaAllergy, 2003
- Churg-Strauss syndromeThe American Journal of Medicine, 2003
- Linksventrikuläre Dysfunktion im Rahmen von Churg-Strauss-SyndromClinical Research in Cardiology, 2003
- Churg-Strauss syndromeThe Lancet, 2003
- Churg-Strauss syndrome with critical endomyocardial fibrosis: 10 year survival after combined surgical and medical managementHeart, 2002
- Epidemiology of systemic vasculitis: A ten-year study in the United KingdomArthritis & Rheumatism, 2000
- EosinophiliaNew England Journal of Medicine, 1998
- Cardiotoxicity as a dose-limiting factor in a schedule of high dose bolus therapy with interleukin-2 and alpha-interferon. An unexpectedly frequent complicationCancer, 1994
- Recurrence of Churg Strauss vasculitis in a transplanted heart.Heart, 1993
- Cyclophosphamide Therapy of Severe Systemic Necrotizing VasculitisNew England Journal of Medicine, 1979